CD274 and neoplasm: However, we were able to employ two flow cytometry panels that included multiple T cell checkpoint molecules (PD-1, TIM-3, LAG-3) on anti-tumor T cell effector populations and immunosuppressive markers (PD-L1, PD-L2) on immunosuppressive myeloid subsets.